艾司洛尔对阵发性室上性心动过速的疗效与安全性  

EFFICACY AND SAFETY OF ESMOLOL FOR PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA

作　　者：徐万群[1] 修红[1] 马先福[1] 

机构地区：[1]青岛大学医学院附属医院急救中心,山东青岛266003

出　　处：《青岛大学医学院学报》2007年第1期51-52,共2页Acta Academiae Medicinae Qingdao Universitatis

摘　　要：目的评价艾司洛尔治疗阵发性室上性心动过速（PSVT）的即时性疗效。方法38例PSVT病人，均静脉注射艾司洛尔，用药前后和PVST终止时，记录病人血压、心率及全导联心电图并观察疗效。结果本组病人显效27例，有效8例，总有效率为92％；起效时间1～56min，平均（7．2±2．8）min多数病人艾司洛尔用量为200mg，少数病人用至400mg。部分病人出现轻度血压降低，头晕，恶心，P-R间期及QTC间期延长，一过性房室传导阻滞等，未经处理均自行缓解。结论艾司洛尔静脉注射终止PVST快速、安全、有效。Objective To evaluate the timely efficacy of esmolol on paroxysmal supraventricular tachycardia（PSVT）. Methods The 38 PSVT patients were given intravenous esmolol. The blood pressure, ventricular heart rate and ECG were recorded, before and after medication, and the efficacy evaluated. Results The efficacy rate of esmolol was 92%, and the reacting time was 1-56 min. The dosage of esmolol was 200 mg for most patients and a few were given 400 mg. Mild hypotension, nausea, dizzy, elongation of P-R interval or QTC interval occurred in some patients and relieved without any treatments. Conclusion Intravenous esmolol is effective and safe for PSVT.

关 键 词：艾司洛尔 心动过速 室上性 治疗结果 

分 类 号：R541.71[医药卫生—心血管疾病]